Taking Antipsychotic Drugs While Pregnant May Harm Newborns: Study

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

According to a study, babies born to women on antipsychotic drugs are more likely to spend time in a neonatal intensive care unit (NICU) or to need specialized care after birth. Lead investigator, Jayashri Kulkarni, director of the Monash Alfred Psychiatry Research Center said, “This new research confirms that most babies are born healthy, but many experience neonatal problems, such as respiratory distress.” The 7-year observational study found that 43 percent of the babies born to the women on antipsychotic drugs spent time in a special care nursery or NICU. While the study found an association between use of these medications during pregnancy and certain neonatal problems, it did not prove a cause-and-effect relationship.
Via U.S. News. Posted June 4, 2014.
–Alanna McCatty


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement